2015-2019 Future Horizons and Growth Strategies in the UK Transfusion Diagnostic Testing Market: Supplier Shares and Country Forecasts

September 2015 | 422 pages | ID: 24860225C23EN
Venture Planning Group

Abstracts

Complete report $6,100. DataPack (test volumes, sales forecasts, supplier shares) $3,950. This comprehensive report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the UK transfusion diagnostic market during the next five years, and assist industry executives in developing effective business, new product development and marketing strategies. The report explores future marketing and technological trends in UK; provides test volume and sales forecasts by market segment/test location; compares features of major automated and semi-automated analyzers; profiles leading and emerging competitors; and identifies specific product and market opportunities facing suppliers during the next five years. Blood Typing and Grouping TestsABO, Antibody Panels, Antibody Screening/Indirect Antiglobulin, Antigen Typing (C, c, Duffy, E, e, I, i, Kell, Kidd, Le a, b, MN, P, S, s), Antiglobulin (Direct, C3 + IgG, IgG, C3), Crossmatching (Immediate Spin, Full Crossmatch), Rh (D, Du). Infectious Disease Screening TestsAIDS (HIV NAT, HIV-1/2), Cytomegalovirus, Hepatitis (HAV NAT, HBV NAT, HBs Ag, Anti-HBc, HCV NAT, HCV, ALT/SGPT), HTLV-I/II, Parvovirus B19 NAT, Syphilis, West Nile Virus NAT. Sales and Market Share AnalysisSales and market share estimates for leading suppliersof transfusion diagnostic products by individual product. Competitive AssessmentsStrategic assessments of major suppliers and emerging market entrants, including their sales,product portfolios, marketing tactics, and new products in R&D. Market Segmentation Analysis- Comprehensive market segmentationanalysis, including review of the marketdynamics, trends, structure, size, growth, and key suppliers. - Test volume and sales forecasts for over 40 blood typing, grouping and infectious disease screening tests,including NAT, by country and market segment:- Blood Centers- Hospitals- Commercial/Private LaboratoriesCurrent and Emerging Products- Analysis of current and emerging blood typing, grouping and infectious disease screening tests. - Review of automated and semi-automated analyzers. Technology Review- Assessment of current and emergingtechnologies, and their potential applicationsfor the transfusion diagnostics market. - Comprehensive lists of companies developingor marketing new technologies and products, by test.

Strategic Recommendations

• New product development opportunitieswith significant market appeal.
• Alternative market penetration strategies.
• Potential market entry barriers and risks

Contains 422 pages and 39 tables

Contents

I. INTRODUCTION

II. WORLDWIDE TECHNOLOGY AND MARKET OVERVIEW

A. Major Blood Typing, Grouping and Infectious Disease Screening Tests
  1. Blood Typing and Grouping Tests
  2. Infectious Disease Screening Tests
    a. AIDS
    b. Hepatitis
    c. Cytomegalovirus
    d. Syphilis
    e. West Nile Virus
    f. Parvovirus B19
    g. Creutzfeldt-Jakob’s Disease
    h. Malaria
    i. Chagas Disease
    j. Babesiosis
  3. Pathogen Reduction
  4. Leukocyte Reduction
B. Instrumentation Review: Operating Characteristics, Features and Selling Prices of Leading Automated and Semiautomated Analyzers
C. Major in Vitro Diagnostic Technologies And Their Potential Applications
  1. Molecular Diagnostics
  2. Monoclonal and Polyclonal Antibodies
  3. Immunoassays
  4. Microtitration Plates
  5. IT and Automation
  6. Lasers
  7. Robotics
  8. Synthetic Red Cell Substitutes
  9. Genetically Engineered Blood Components
  10. Blood Preservation
  11. Autologous Blood Transfusion/Freezing

III. SPAIN

A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth and Major Suppliers’ Sales and Market Shares for Blood Typing, Grouping and Infectious Disease Screening Tests

IV. MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES

A. Blood Typing and Grouping
B. Infectious Disease Screening
C. Auxiliary

V. ALTERNATIVE MARKET PENETRATION STRATEGIES

A. Internal Development
B. Collaborative Arrangements
C. University Contracts

VI. POTENTIAL MARKET ENTRY BARRIERS AND RISKS

A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection

VII. COMPETITIVE ASSESSMENTS

Abbott
Beckman Coulter/Danaher
Becton Dickinson
Biokit
BioMerieux
Bio-Rad
Diagast
DiaSorin
Fujirebio/Innogenetics
Hologic/Gen-Probe
Grifols
Immucor
Novartis Diagnostics
Ortho-Clinical Diagnostics
Orchid CellMark
Proteome Sciences
Quest Diagnostics
Quidel
Roche
Siemens
Tecan

XII. APPENDIX: ASSUMED CURRENCY EXCHANGE RATES

List Of Tables

LIST OF TABLES

Major Companies Developing or Marketing Blood Typing and Grouping Tests
Major Companies Developing or Marketing HLA Typing Tests
Major Companies Developing or Marketing AIDS Tests
Major Companies Developing or Marketing Hepatitis Tests
Major Companies Developing or Marketing CMV Tests
Major Companies Developing or Marketing Syphilis Tests
Major Companies Developing or Marketing Blood Bank Analyzers
Executive Summary Table: Spain, Total Blood Bank Test Volume and Reagent Sales Forecast by Test Category
Spain, Facilities Performing Blood Bank Tests by Market Segment
Spain, Hospital Laboratories Performing Blood Bank Tests by Bed Size
Spain, Commercial/Private Laboratories Performing Blood Bank Tests by Annual Test Volume
Spain, All Market Segments Blood Typing And Grouping Test Volume Forecast By Market Segment
Spain, All Market Segments Blood Typing and Grouping Test Volume Forecast
Spain, Hospital Laboratories Blood Typing and Grouping Test Volume Forecast
Spain, Blood Banks Blood Typing And Grouping Test Volume Forecast
Spain, Commercial/Private Laboratories Blood Typing and Grouping Test Volume Forecast
Spain, All Market Segments Infectious Disease Screening Test Volume Forecast By Market Segment
Spain, All Market Segments Infectious Disease Screening Test Volume Forecast
Spain, Blood Banks Infectious Disease Screening Test Volume Forecast
Spain, Commercial/Private Laboratories Infectious Disease Screening Test Volume Forecast
Spain, Hospital Laboratories Infectious Disease Screening Test Volume Forecast
Spain, All Market Segments Blood Typing And Grouping Reagent Market Forecast By Market Segment
Spain, All Market Segments Blood Typing And Grouping Reagent Market Forecast by Major Test
Spain, Hospital Laboratories Blood Typing and Grouping Reagent Market Forecast By Major Test
Spain, Blood Banks Blood Typing and Grouping Reagent Market By Major Test Forecast
Spain, Commercial/Private Laboratories Blood Typing and Grouping Reagent Market Forecast By Major Test
Spain, All Market Segments Infectious Disease Screening Reagent Market Forecast by Market Segment
Spain, All Market Segments Infectious Disease Screening Reagent Market Forecast by Test
Spain, Blood Banks Infectious Disease Screening Reagent Market Forecast by Test
Spain, Commercial/Private Laboratories Infectious Disease Screening Reagent Market Forecast By Test
Spain, Hospital Laboratories Infectious Disease Screening Reagent Market Forecast by Test
Spain, Major Suppliers of Blood Typing And Grouping Reagents Estimated Sales And Market Shares
Spain, HIV-1/2 Blood Screening Market, Reagent Sales by Major Supplier
Spain, Hepatitis Blood Screening Market, Reagent Sales by Major Supplier
Spain, HIV/Hepatitis NAT Market, Reagent Sales by Major Supplier
Spain, CMV Blood Screening Market, Reagent Sales by Major Supplier
Spain, Syphilis Blood Screening Market, Reagent Sales by Major Supplier